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Isolated limb perfusion with tissue plasminogen
activator for acute hand ischemia
Ramyar Gilani, MD, Roy K. Greenberg, MD, and Douglas R. Johnston, MD, Cleveland, Ohio
A 62-year old woman presented with an ischemic hand postoperatively from an open abdominal aortic aneurysm repair.
Traditional open embolectomy techniques were attempted but failed < 24 hours. She was then taken for isolated limb
perfusion with tissue plasminogen activator for ongoing ischemia of the hand. A satisfactory technical result was achieved,
and the patient remains with a functional extremity. ( J Vasc Surg 2009;50:659-62.)The efficacy of intra-arterial thrombolytic therapy for
acute arterial ischemia has been validated by several pro-
spective randomized control trials.1-3 Despite its safe use,
intra-arterial thrombolysis has limitations with respect to
the time required to achieve reperfusion in the setting of
advanced ischemia in addition to the risks of local and
systemic bleeding complications. These drawbacks force
clinicians to pursue other therapy alternatives under certain
clinical settings. The desire to rapidly reperfuse tissue (in-
cluding the distal circulation), remove the toxins that have
developed in the ischemic musculature, and prevent recur-
rent thrombosis in a complication free manner is the goal of
treatment for limb ischemia.
The use of isolated limb perfusion (ILP) to treat malig-
nancies, such as advanced limbmelanoma and sarcoma4,5 is
well established; however, the application of similar ap-
proaches for acutely ischemic limbs is less common. The
technique used for hyperthermia and chemotherapy ad-
ministration was modified and described in the context of a
canine model with the intent of an application towards
acute arterial ischemia.6 Subsequent cases have been de-
scribed7-9 and represent a treatment option for urgent
revascularization in the setting of thrombosed distal circu-
lation of the lower extremity. This article describes a mod-
ified ILP technique to address profound upper extremity
ischemia.
CASE REPORT
A 62-year old woman with a medical history of hypertension
and chronic obstructive pulmonary disease underwent open repair
of an infrarenal abdominal aortic aneurysm and a right common
iliac artery aneurysm through a midline approach. Her postopera-
tive course was complicated by an episode of respiratory distress
obligating a return to the surgical intensive care unit and the need
for invasive blood pressure monitoring by way of a brachial arterial
catheter placed in the left arm.
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doi:10.1016/j.jvs.2009.04.039On postoperative day 9, she was found to have an ischemic left
hand and forearm caused by the brachial arterial catheter. The
hand and forearm were cyanotic and insensate, with weakened
strength. She was taken for an open brachial artery thrombectomy.
At the completion of this procedure, pulses were restored and
triphasic signals were present at the level of the wrist; however, 24
hours later the hand showed signs of worsening ischemia despite
improvement of the forearm.
She was taken to the operating room, where an angiogram
(Fig 1) showed no filling of the radial and ulnar arteries at the
wrist or any appreciable filling within the hand. In light of her
recent surgery and residual distal thrombus burden, a decision
was made to proceed to ILP with tissue plasminogen activator
(TPA) rather than catheter-directed lysis. An isolated limb
perfusion circuit was created using a cardiotomy reservoir
(Medtronic Inc, Minneapolis, Minn), bubble trap, and a single
roller pump (Fig 2). Oxygen was delivered directly to the
cardiotomy reservoir, thus eliminating the need for an oxygen-
ator at these low flow rates. Oxygen levels were monitored and
flow rates adjusted appropriately.
The brachial artery was surgically exposed and accessed with a
10F pediatric arterial cannula (Medtronic Inc). The arterial seal
was maintained with a small vessel loop tourniquet. The venous
cannulation was established using a 12F pediatric metal-tip right-
angle venous cannula (Medtronic Inc) with proximal occlusion of
the vein using a vessel loop with a good seal. A tourniquet was
applied to the upper arm, and systemic heparin was administered
to maintain an activated clotting time (ACT) of 250 to 300
seconds. The pump was primed with 1 U of packed red blood
cells, 10,000 U of heparin, 25 mEq of sodium bicarbonate, and
500 mL of Plasma-lyte (Baxter International, Inc, Deerfield,
Ill). The oxygen flow rate to the cardiotomy reservoir was 2 to 5
L/min. We decided to add 25 mg of TPA (Genentech, Inc,
South San Francisco, Calif) to the venous line of the perfusion
system.
The limb was perfused at a flow rate of 175 to 225 mL/min.
Throughout the perfusion, the ACT from the isolated limb circuit
was maintained 600 seconds using additional heparin when
necessary. The hand had not improved markedly 1 hour after the
onset of limb perfusion, and an additional 25mg of TPAwas added
to the circuit. Perfusion was maintained until the hand showed
signs of clinical improvement.
Marked improvement occurred after about 2 hours of limb
perfusion. At this time, the entire circuit (hand and forearm) was
flushed with fresh Plasma-lyte to remove as much TPA and isch-
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vessels were repaired. The proximal tourniquet was taken down,
and a completion angiogram (Fig 3) was obtained. Hand and
forearm fasciotomies were performed due to the severity of the
ischemia.
After 5 days, a Vacuum Assisted Closure (V.A.C.) dressing
Fig 1. Initial arteriogram.
Fig 2. Perfusion circuit.(Kinetic Concepts, Inc, San Antonio, Tex) was applied to thefasciotomy sites before the patient was discharged. Clinically, the
hand remained pink with good capillary refill, with the exception of
the distal skin on her first, third, and fifth digits, with intact sensory
and motor function (Fig 4). The patient remained in the hospital
for an additional 5 days to transition from heparin to Coumadin
(Bristol-Myers Squibb, Princeton, NJ) and to receive occupational
therapy. She was discharged with a functional extremity.
DISCUSSION
Acute thromboembolism of the arterial bed within an
extremity incurs a significant risk of limb loss. Traditional
techniques to restore flow to an ischemic limb have in-
cluded open balloon thromboembolectomy and surgical
bypass grafting. Despite the clinical efficacy, however, con-
siderable residual thrombus can remain within the distal
arterial bed even after the best attempts with balloon cath-
eters.10 This deficiency in treatment creates the role for
thrombolysis that has been validated through prospective
randomized control trials.1-3
Thrombolysis is not without risks and limitations, how-
ever. Major hemorrhage is a real concern, especially in
patients with risk factors for bleeding complications during
thrombolytic therapy, including recent surgery and previ-
ous bleeding episodes. Patients who present with severe
limb ischemia and neurologic deficits also may incur irre-
versible damage unless perfusion is established expedi-
tiously. These patients are therefore often treated with
traditional open surgical techniques despite increased risks;
however, this has not been successful when the distal cir-
culation is heavily involved.
The use of ILP within the surgical oncology literature
has been documented for nearly 50 years, and its use for
local regionally unresectable melanoma and sarcoma of the
Fig 3. Completion angiogram.extremities is well established. Briefly, the technique estab-
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through an artery and a vein. The flow circuit consists of a
reservoir, bubble trap, roller pump, and oxygenator. Spe-
cific additives can then be added to the perfusate to achieve
the desired effect.
During the treatment, the limb circulation is quaran-
tined from the systemic circulation by means of a tourni-
quet to avoid systemic toxicities of the additives. Once the
treatment is completed, the limb is flushed, the circuit is
disconnected, and flow is reestablished within the extrem-
ity. By adding thrombolytic agents to the perfusate, ILP
can become applicable to acute arterial ischemia of an
extremity. Its application is further warranted by the need
for rapid reperfusion in the setting of thrombosed distal
circulation presenting with severe ischemia. ILP with
thrombolysis has been shown to be an effective method of
administering lytic therapy.6 The authors concluded that
higher concentrations of lytic agents can be used with ILP,
resulting in a shorter duration of ischemia and potentially
limiting permanent neurologic injury.
ILP has been used to treat thrombosed popliteal artery
aneurysms7 as well as thrombosed femoral artery bypass
Fig 4. Hand after 3 weeks of follow-up.grafts9 with favorable results. Different schematics havebeen used for performing limb perfusion and range from
simply infusing lytic into the arterial bed while draining the
venous effluent through a catheter to establishing an extra-
corporeal circuit while adding specific additives to the
perfusate.11
Our addition of oxygen to the circuit provides an
additional potential mechanism by which ongoing ischemia
can be treated while maintaining an environment where
high concentrations of lytic agents can be used locally and
then removed from the circulation before restoration of
native limb flow. Furthermore, we hypothesize that such a
technique allows for the removal of other ischemic toxins
that have accumulated within the damaged tissue, limiting
their systemic effects such as renal dysfunction and meta-
bolic derangements.
CONCLUSION
Prompt open embolectomy remains the first line
therapy for acute ischemia, but may not be sufficient
when the thrombosis extends into the hand and digits.
We demonstrate a technique that combines ILP with
thrombolysis to manage hand ischemia resulting from
suspected distal circulation thrombosis. The isolated cir-
cuit, supplementation of oxygen, and high concentra-
tions of lytic agents may allow for relatively rapid reper-
fusion with the ability to remove the harmful byproducts
of severe ischemia.
Recent major surgical procedures are a relative contra-
indication of catheter-directed lysis given the significant
bleeding risks. It seems logical that where such circuits are
readily available, ischemia reticent to conventional methods
of reperfusion would be considered rather than amputa-
tion. Therefore, ILP with TPA is indicated when significant
distal arterial thrombus exists in the setting of a contrain-
dication to traditional catheter-directed thrombolysis tech-
niques.
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